PT66781A - Procede pour la preparation des derives de la phenoxy-hydroxypropylamine - Google Patents

Procede pour la preparation des derives de la phenoxy-hydroxypropylamine

Info

Publication number
PT66781A
PT66781A PT66781A PT6678177A PT66781A PT 66781 A PT66781 A PT 66781A PT 66781 A PT66781 A PT 66781A PT 6678177 A PT6678177 A PT 6678177A PT 66781 A PT66781 A PT 66781A
Authority
PT
Portugal
Prior art keywords
phenoxy
preparation
hydroxypropylamine
derivatives
hydroxypropylamine derivatives
Prior art date
Application number
PT66781A
Other languages
English (en)
Portuguese (pt)
Other versions
PT66781B (fr
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie filed Critical Hexachimie
Publication of PT66781A publication Critical patent/PT66781A/fr
Publication of PT66781B publication Critical patent/PT66781B/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
PT66781A 1976-07-22 1977-07-08 Procede pour la preparation des derives de la phenoxy-hydroxypropylamine PT66781B (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3064776 1976-07-22
GB5357676 1976-12-22

Publications (2)

Publication Number Publication Date
PT66781A true PT66781A (fr) 1977-08-01
PT66781B PT66781B (fr) 1978-12-18

Family

ID=26260544

Family Applications (1)

Application Number Title Priority Date Filing Date
PT66781A PT66781B (fr) 1976-07-22 1977-07-08 Procede pour la preparation des derives de la phenoxy-hydroxypropylamine

Country Status (11)

Country Link
JP (1) JPS5312851A (fr)
AU (1) AU2714177A (fr)
DE (1) DE2733305A1 (fr)
DK (1) DK329577A (fr)
ES (1) ES460866A1 (fr)
FR (1) FR2359135A1 (fr)
GR (1) GR61995B (fr)
NL (1) NL7707949A (fr)
NO (1) NO772604L (fr)
PT (1) PT66781B (fr)
SE (1) SE7708368L (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160154U (ja) * 1983-03-01 1983-10-25 セイコーエプソン株式会社 印字装置
GB0319069D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Therapeutically useful compounds
JP5299810B2 (ja) 2004-02-27 2013-09-25 アムジエン・インコーポレーテツド 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
WO2007033002A1 (fr) 2005-09-14 2007-03-22 Amgen Inc. Acides propanoïques 3-substitués par un groupement 4-hydroxyphényle à conformation contrainte pouvant être employés dans le traitement de troubles métaboliques
AU2007292816B2 (en) 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
CA2662305C (fr) 2006-09-07 2012-04-17 Amgen Inc. Modulateurs heterocycliques du recepteur couple a la proteine g (gpr40)
EP2139843B1 (fr) 2007-04-16 2013-12-25 Amgen, Inc Modulateurs de gpr40 des acides biphényle phénoxy, thiophényle et aminophénylpropanoïque substitués
CN102083783A (zh) 2007-10-10 2011-06-01 安姆根有限公司 取代的联苯gpr40调节剂
WO2009111056A1 (fr) 2008-03-06 2009-09-11 Amgen Inc. Dérivés d'acide carboxylique conformationnellement dépendants, utiles dans le traitement de troubles du métabolisme
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
CN120230084A (zh) * 2023-12-28 2025-07-01 赛岚(杭州)生物医药科技有限公司 一种tdg抑制剂化合物及其用途

Also Published As

Publication number Publication date
ES460866A1 (es) 1978-08-16
AU2714177A (en) 1979-01-25
DK329577A (da) 1978-01-23
FR2359135A1 (fr) 1978-02-17
JPS5312851A (en) 1978-02-04
DE2733305A1 (de) 1978-01-26
NO772604L (no) 1978-01-24
NL7707949A (nl) 1978-01-24
PT66781B (fr) 1978-12-18
SE7708368L (sv) 1978-01-23
GR61995B (en) 1979-02-14

Similar Documents

Publication Publication Date Title
RO70769A (fr) Procede pour la preparation des derives de 2-phenyle-3-acylbenzothiophene
RO82375A (fr) Procede pour la preparation des derives de 9-aminodibenzopyrane
RO70768A (fr) Procede pour la preparation des derives de 2-aryle-5-phenylbenzothiophene
RO73517A (fr) Procede pour la preparation des derives aminoglycosidiques
PT64912B (fr) Procede pour la preparation de derives de salicilanilide
RO70854A (fr) Procede pour la preparation des metha-aryloxybenzaldehydes
RO80925A (fr) Procede pour la preparation des derives de nitrothiofene
RO79164A (fr) Procede pour la preparation des derives de 1-allyle-triazole
PT66781B (fr) Procede pour la preparation des derives de la phenoxy-hydroxypropylamine
RO78658A (fr) Procede pour la preparation des derives des antraquinonsulfonamides
RO70462A (fr) Procede pour la preparation des 3-halomethylcephem
RO76588A (fr) Procede pour la preparation des derives de 1,3,4-tridiazole
RO78091A (fr) Procede pour la preparation des derives de 1-azoletene
RO71572A (fr) Procede pour la preparation des oxycarbamates n-sulphenyles
RO71066A (fr) Procede pour la preparation des 2-chlorsulfinylazetidin-4-ones
RO79264A (fr) Procede pour la preparation des derives de oleandomicine
RO72900A (fr) Procede pour la preparation des cis-4a-phenyloctahydro-1h-2-pyrindines
PT71444A (fr) Procede pour la preparation de derives de benzimydazole
FR2351967A1 (fr) Procede de preparation de derives de 3-benzazepines
RO80266A (fr) Procede pour la preparation des derives de 1-amino-2-alcoolpropylique
RO78802A (fr) Procede pour la preparation des derives de n-trifluoraracetyle-n-phosphonomethylglycine
RO83713A (fr) Procede pour la preparation des haloacylamides
BE879821A (fr) Procede selectif pour la preparation de derives de 7-hydroxy-coumarine
RO76125A (fr) Procede pour la preparation des derives de furanne
FR2366259B1 (fr) Procede de preparation de derives de nitroalcanols